NewsRx

Search our medical news database

A.M. Best Co.

A.M. Best Affirms Ratings of Central States Indemnity Co. of Omaha

Published in Managed Care Weekly Digest, June 25th, 2012

2012 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- A.M. Best Co. has affirmed the financial strength rating of A+ (Superior) and issuer credit rating of "aa-" of Central States Indemnity Co. of Omaha (CSI) (Omaha, NE). The outlook for both ratings is stable.

The ratings reflect CSI's excellent risk-adjusted capitalization, consistently profitable operating performance, favorable balance sheet liquidity and extremely conservative underwriting leverage, as well as the benefits made available though its ultimate parent, Berkshire Hathaway, Inc. [NYSE: BRK A and BRK B]. CSI is a specialty insurance company that provides...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook